Welcome to our dedicated page for Transact Tech SEC filings (Ticker: TACT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The TransAct Technologies Inc. (NASDAQ: TACT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. TransAct files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K covering financial results, material agreements and other significant corporate events.
Recent 8-K filings describe preliminary quarterly financial results, including net sales, gross profit, operating income or loss, net income or loss, EBITDA and adjusted EBITDA, as well as FST recurring revenue and casino and gaming net sales. These filings often attach press releases as exhibits and explain the company’s use of non-GAAP measures such as EBITDA and adjusted EBITDA, including why management and lenders consider them useful in evaluating operating performance.
Other 8-Ks detail material definitive agreements, such as the Source Code Purchase and Perpetual License Agreement with Avery Dennison for BOHA™ source code and a Third Amendment to the company’s headquarters lease in Hamden, Connecticut. These documents outline key terms, payment milestones, license rights and lease modifications that can affect TransAct’s operations and cost structure.
Through Stock Titan, users can follow TransAct’s real-time filing activity as new documents are posted to EDGAR, and then use AI-powered tools to summarize and interpret lengthy reports. This includes quickly understanding the main points in 10-K and 10-Q filings, reviewing 8-K disclosures about earnings releases and agreements, and examining exhibits related to technology licensing or facilities. The filings page is a resource for investors who want to analyze TransAct’s financial reporting, risk disclosures and contractual commitments directly from its official SEC submissions.
TransAct Technologies describes a year of continued investment in its food service technology platform and ongoing risks in its annual report for the year ended December 31, 2025. The company, a global provider of BOHA! back-of-house systems, POS printers and casino gaming printers, operates as a single reporting segment with 103 employees and broad international distribution.
TransAct reports net losses of $1.2 million in 2025 and $9.9 million in 2024, after earning $4.7 million in 2023, and warns it may not sustain profitability as it spends heavily on FST product development and marketing. A major 2025 development is a $2.55 million perpetual, royalty-free license to the BOHA! source code from Avery Dennison, plus about $1.0 million in transition services, which is intended to give the company long‑term control over core software but carries execution risk during migration and insourcing.
The report highlights dependence on a single contract manufacturer in Thailand for most printers and terminals and on Light & Wonder, which accounted for 9% of 2025 net sales, as key operational and customer concentration risks. TransAct also outlines cyber and supply chain vulnerabilities, competitive pressure in FST, POS and gaming markets, and restrictive covenants under its Siena Credit Facility, which require minimum excess availability of $750 thousand and at least $3 million of borrowings outstanding. As of February 28, 2026, there were 10,239,045 common shares outstanding, and non‑affiliate equity market value was approximately $32 million based on the June 30, 2025 share price.
TransAct Technologies reported preliminary results showing solid growth for 2025 and a much smaller loss. Net sales rose to $51.5M from $43.4M, driven by its BOHA! food service technology and casino and gaming businesses. BOHA! terminal sales increased 36% to 7,317 units, and full-year net sales grew 19% with recurring FST revenue up 14%.
The company cut its net loss to $1.2M from $9.9M, while adjusted EBITDA improved to $1.2M from a loss of $1.5M. For 2026, TransAct guides to revenue of $55–$57M, emphasizing higher-margin software as its main growth engine and continued cash generation from casino and gaming to fund FST investments.
TRANSACT Technologies President and CFO Steven A. DeMartino reported equity award activity involving restricted stock units and common stock. On March 4, 2026, he exercised 12,500 restricted stock units, which converted into 12,500 shares of common stock at a stated price of $0.0000 per share.
The restricted stock units were originally issued on September 4, 2024 under the company’s 2014 Equity Incentive Plan, vesting in eight equal quarterly installments over two years. After the conversion, DeMartino held 25,000 restricted stock units and 192,089 shares of common stock directly.
To cover tax obligations related to the award, 4,240 shares of common stock were disposed of in a tax-withholding transaction coded “F” at $3.4800 per share. Following these transactions, DeMartino’s direct ownership stood at 187,849 shares of common stock.
TransAct Technologies Incorporated amended and restated its corporate by-laws, with the changes becoming effective on February 25, 2026, following approval by the Board of Directors. The company has filed the full text of the amended and restated by-laws as Exhibit 3.1, marked to show changes from the prior version.
TransAct Technologies Inc. insiders reported indirect acquisitions of common stock through restricted stock unit (RSU) conversions. On February 27–March 1, 2026, RSUs previously granted under the company’s 2014 Equity Incentive Plan were exercised or converted into common shares at $0.00 per share under code M.
The transactions include RSUs issued on March 1, 2023, February 29, 2024, and February 27, 2025, each vesting 25% annually and converting to common stock on a one-for-one basis. Reported amounts include, for example, 2,850 and 1,675 common shares acquired indirectly.
The filing is made jointly by 325 Capital LLC, 325 Capital Master Fund LP, 325 Capital GP, LLC, and individuals including director Daniel M. Friedberg and Anil K. Shrivastava, who may be deemed to share pecuniary interests and beneficial ownership but each disclaims beneficial ownership except to the extent of any pecuniary interest.
TransAct Technologies director Haydee Olinger reported multiple equity award conversions into common stock. On February 27, 28 and March 1–2, 2026, Restricted Stock Units granted under the company’s 2014 Equity Incentive Plan converted to common stock on a one-for-one basis at a price of $0.00 per share.
The transactions reflect derivative exercises or conversions, increasing directly held common stock through vesting of prior RSU grants from 2022, 2023, 2024 and 2025, each vesting 25% annually starting on the first anniversary of grant.
TransAct Technologies director Emanuel N. Hilario reported acquiring a total of 7,375 shares of common stock through exercises of restricted stock units between February 27, 2026 and March 2, 2026 at a price of 0.00 per share. Each restricted stock unit converted into one share of common stock under the company’s 2014 Equity Incentive Plan, which provides for annual vesting starting one year after grant.
After these derivative exercises and conversions, Hilario directly owns 29,100 shares of TransAct Technologies common stock. These transactions reflect the vesting and settlement of equity awards rather than open‑market purchases or sales.
TransAct Technologies Inc. director Randall S. Friedman reported multiple stock award vestings that converted into common shares. On February 27, 28, March 1 and March 2, 2026, he exercised Restricted Stock Units into matching amounts of common stock at a price of $0.0000 per share.
The RSUs were originally granted between 2022 and 2025 under the company’s 2014 Equity Incentive Plan, vesting 25% annually and converting on a one-for-one basis into common stock. After these conversions, Friedman directly owned 21,800 shares of TransAct common stock, with no reported share sales.
TransAct Technologies director Audrey Dunning increased her direct common stock holdings through equity awards converting into shares. On February 27, February 28, and March 1, 2026, she exercised restricted stock units granted under the company’s 2014 Equity Incentive Plan, Amended and Restated, into common stock on a one-for-one basis at a reported price of $0.00 per share. Following these conversions, her directly owned common stock position is reported at 17,600 shares.
TransAct Technologies’ Chief Technology Officer Brent Richtsmeier reported a series of equity award conversions into common stock. On February 28 and March 1–2, he exercised vested restricted stock units and performance stock units, each converting to common stock on a one-for-one basis at a price of $0.00 per share. These were non‑cash transactions reflecting the vesting of awards under the company’s 2014 Equity Incentive Plan. Following the latest reported conversion on March 2, his direct ownership in common stock increased to 29,998 shares.